From the
Department of Chemistry and Biochemistry
and the Molecular Biology Institute, University of California, Los Angeles,
California 90095 and the ¶Department of
Biological Sciences, Columbia University, New York, New York 10027
Received for publication, March 28, 2003
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Cells normally acquire Q through de novo synthesis, and the length of the prenyl tail varies among different organisms (12). Saccharomyces cerevisiae produce Q6, which has six isoprene units, whereas E. coli synthesize Q8, and humans synthesize Q10. Eight COQ genes have been identified to be required for Q synthesis in S. cerevisiae (13, 14). Fig. 1 shows the pathway for Q biosynthesis in both prokaryotes and eukaryotes. In yeast, mutation in any of the eight COQ genes results in cells that cannot synthesize Q and fail to grow on nonfermentable carbon sources. Yeast coq3coq8 mutants each accumulate the same early intermediate in Q biosynthesis, 3-hexaprenyl-4-hydroxybenzoic acid (Fig. 1, HHB or compound 1) (15).
|
In this work the yeast COQ6 gene has been isolated by functional complementation of a mutant from the G63 (coq6) complementation group. Transformation of coq6 mutant strains with a plasmid bearing wild type COQ6 restores Q biosynthesis and growth on nonfermentable carbon sources. In contrast to a previous report (16), we find COQ6 to be a nonessential gene. Here we show the Coq6 polypeptide is imported into mitochondria and is peripherally associated with the inner membrane on the matrix side. Based on sequence analysis and alignment with other known hydroxylases, the proposed function of Coq6 polypeptide is that of a flavin-dependent monooxygenase required for one or more steps in Q biosynthesis.
![]() |
EXPERIMENTAL PROCEDURES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
Cloning of the COQ6 GeneThe haploid strain SR128-3C
containing the coq6-1 allele was obtained from mating C128 and FY250
(Table I). SR128-3C yeast were
grown to early-log phase in YPD medium and transformed
(20) with the YCp50
centromeric plasmid library of S. cerevisiae genomic DNA
(21) containing the
URA3 gene as a selectable marker. Transformants were selected on
SDUra plates and after a 3-day incubation at 30 °C were
replica-plated onto YPG plates to test for respiratory growth. Putative Q
prototrophic transformants, able to grow on medium containing a nonfermentable
carbon source, were further purified and tested for co-segregation of uracil
prototrophy and respiration competency following vegetative growth in rich
medium. Such co-segregation was observed in two transformants, indicating that
these traits were plasmid-linked. Yeast plasmid DNA was recovered from one
transformant (494SR) and was amplified in DH5 E. coli
(Invitrogen). The plasmid p494SR contained an insert of 4.1-kb and
transformation of SR128-3C with p494SR restored growth on YPG medium. A
similar cloning procedure was also performed with a multicopy expression
library prepared from yeast genomic DNA in the vector YEp24
(22) and resulted in the
isolation of pG63/T1, which was found to contain a 2.8-kb segment of DNA that
overlapped with the insert present in p494SR
(Fig. 2). Seven other rescuing
yeast genomic DNA clones were similarly isolated from a recombinant pUV1-based
plasmid library (generous gift of Junichi Nikawa and Michael Wigler, Cold
Spring Harbor Laboratory). Southern analysis showed that all of the clones
contained overlapping DNA fragments (data not shown).
|
Subcloning and Disruption of the COQ6 GeneA 3.8-kb HindIII fragment was isolated from p494SR and was ligated to the HindIII site of pRS316 (23) to generate pSR1-1. The insert of pSR1-1 was sequenced and found to contain two ORFs located on a segment of chromosome VII. Only one ORF, YGR255C, was also present on pG63/T1, and was designated COQ6 (deposited in GenBankTM with accession number AF003698 [GenBank] ).
To construct a disruption allele of COQ6, a 2.9-kb
HindIII fragment, containing about 350 bp of the YEp24 sequence and
2.55 kb of yeast genomic DNA, was excised from pG63/T1 and inserted into the
HindIII site of YEp352 to generate the plasmid pG63/ST2. As shown in
Fig. 2, the coq6
deletion plasmid was constructed by replacing a 414-bp BglII fragment
in pG63/ST2 with a 1.7-kb BamHI fragment containing HIS3
(24). The resulting plasmid,
pG63/ST3 was used to obtain a 4.0-kb EcoRI fragment with the
disrupted gene. W303-1A, W303-1B, and SR128-3C were each transformed with 1
µg of DNA (25). Most of the
histidine prototrophic clones issued from the transformations were
respiration-defective and were complemented by the ° test
strains JM6 or JM8 but not by the coq6-1 mutant strains, implying a
genetic linkage between the coq6
::HIS3 and the
coq6-1 alleles. Nuclear DNA from three independent transformants (one
from each of the three separate parental strains) was digested with
EcoRI and EcoRV, separated on 1% agarose, and transferred to
a nitrocellulose membrane. The probe, a 1.1-kb EcoRI/EcoRV
fragment within the COQ6 ORF, recognizes a 1.1-kb fragment in the
genomic DNA of the parental strain. The genomic DNA of the mutant strains
(W303
COQ6-1,
W303
COQ6-1, and SR
COQ6-1) contained a
larger hybridizing species at
3.15 kb, as expected for the disrupted
allele. To verify the allelism between coq6
and
coq6-1 mutations, SR
COQ6-1 was mated to wild type strain
W303-1A to form diploid cells, which were then sporulated to produce meiotic
progeny. Spores from 14 tetrads showed 2:2 segregation for respiration
competence and histidine auxotrophy. In all cases, the spores competent to
grow on glycerol medium were histidine auxotrophs, whereas the spores unable
to grow on glycerol were histidine prototrophs, confirming the allelism
between the cloned COQ6 gene and the original coq6-1
mutation.
Complete Deletion of the COQ6 ORFA complete deletion of the COQ6 open reading frame was performed with a PCR-targeting strategy (26). A 1.53-kb fragment containing LEU2 was generated from the YEp13 vector (GenBankTM accession number U03498 [GenBank] ) using forward primer pPG6DLF 5'-ATAATTCTTAAAAGTGGAGCTAGTCTATTTCTATTTACATACCTCATTTTGTAATTTCGTGTCG-3' and reverse primer pPG6DLR 5'-TCAAATTGGTCTTTCAGTGAACCTTGTATCGATTGACACAGAGGCAGAGGTCGCCTGACGCATA-3'. The 5' end of the forward primer contained 45 nucleotides corresponding to 45 to 1 upstream of the COQ6 ORF and at the 3' end 19 nucleotides corresponding to nucleotides 55795597 of YEp13. The reverse primer similarly corresponded to 45 nucleotides from +1485 to +1441 of the reverse strand of the COQ6 ORF followed by 19 residues from 7018 to 7000 of the reverse strand of YEp13. A W303-1AB diploid was created by mating W3031A with W3031B. W3031A, W3031B, CEN.PK2-1C, and W303-1AB cells were transformed with 1 µg of the fragment using the lithium-acetate method as described (27). Transformed cells were grown on SDLeu plates at 30 °C for 2 days. Gene disruption was verified by PCR using forward primer Coq6SeqF1 5'-ACCTTTGCATTACAAGTGCAACGCTCTACC-3' and reverse primer Coq6SeqR1 5'-GGTGACGCGTGTATCCGCCCGCTCTTTTGG-3' and produced a product of 1.84-kb for both the wild type and disrupted strains. The PCR product was then digested using the restriction enzyme EcoRI, which digests the wild type product and produces two products of 0.44 and 1.4 kb, whereas the EcoRI digestion fragments of the disrupted product are 1.2 and 0.64 kb. Tetrad analysis was performed as described above.
In Vivo Radiolabeling of Q6 Intermediates,
Lipid Extraction, and Analysis by HPLCYeast strains SR128-3C and
W303COQ6-1 were grown in 1 liter of SDC medium supplemented with 0.65
µCi of 4-[U-14C]hydroxybenzoic acid (365 Ci/mol), synthesized
from L-[U-14C]tyrosine by alkali heat fusion
(28). Cells the were harvested
after 3 days of incubation at 30 °C with shaking (200 rpm,
A600 nm = 10), and the lipids were extracted as described
(29). The lipid extracts were
concentrated, the volume was adjusted to 1 ml with hexane, and 0.10-ml
aliquots (5.012.0 x 103 cpm) were analyzed by normal
phase HPLC employing a cyanopropyl column (Zorbax, 5 µm, 4.6 x 250
mm; Mac-Mod Analytical, Chadds Ford, PA) as described
(30). The column was
equilibrated with a mobile phase composed of 98% solvent A (hexane) and 2%
solvent B (isopropanol:hexane:water:methylene chloride, 52:41: 5:2) at a flow
rate of 1 ml/min. Ten minutes after sample injection, the percentage of
solvent B was increased linearly from 2 to 27% in 25 min (35 min from the
start) and then from 27 to 100% in 20 min (55 min after the start). In the
next 5 min, the percentage of solvent B was decreased linearly from 100 to 2%
and remained at 2% for 30 min to equilibrate the column before next sample
injection. The radioactivity of 1-ml fractions was measured by scintillation
counting in 10 ml of BIOsafe nonaqueous scintillation mixture (Research
Products International) with a Beckman scintillation counter (model LS-3133P).
The efficiency of 14C detection was 90%.
Determination of Q6 Content in Lipid Extracts by HPLC and
Electrochemical DetectionLipid extraction and analysis were
performed as described previously
(31). Yeast strains W303-1A,
SR128-3C, W303COQ6-1, and W303
COQ6-1:pSR1-1 (the
coq6-null strain harboring a COQ6 containing plasmid) were
grown at 30 °C with shaking (200 rpm) in 50 ml of YPGal to an
A600 nm of about 4 or alternatively were grown to
saturation (2 days). 750 ng of Q9 was added as an internal standard
to a yeast cell pellet (100 mg of wet weight), and the cells were lysed by
vortexing with 1 g of glass beads in 0.35 ml of water.
Mitochondrial Import AssayAn in vitro transcription template plasmid was constructed by inserting the COQ6 ORF into the pRS426 vector downstream of the T7 promoter (32). The COQ6 ORF with SalI and NotI linkers at 5' and 3' ends, respectively, was PCR-amplified with the template pSR1-1, 5' primer JF3 (5'-ACGCACGCGTCGACATGTTCTTTTCAAAAGTTATGC-3'), and 3' primer JF41 (5'-ATAAGAATGCGGCCGCTCTCATTTCTCATTTCCTCC-3') using Vent DNA polymerase (New England Biolabs). The PCR product was digested with SalI and NotI and inserted into the corresponding SalI and NotI sites in pRS426. The resulting product, pT7Q6, was linearized with XhoI and provided template DNA for in vitro transcription (Promega Ribomax large scale RNA production system). The resulting mRNA was then translated with Promega Flexi rabbit reticulocyte lysate system in the presence of [35S]methionine from Amersham Biosciences (1000 Ci/mmol, at a final concentration of 0.75 µM). Both the mRNA and the 35S-labeled polypeptides were stored at 80 °C. The isolation of mitochondria (from D273-10B/A1) and import reaction conditions were performed according to Yaffe (33) as described previously (34). The cell cultures (1 liter) were grown in semisynthetic lactate medium to saturation density. The spheroplasts were prepared and lysed by Dounce homogenization with a tight fitting pestle as described (19). Purified mitochondria were isolated from a linear Nycodenz gradient as described (19). Each import reaction contained 6 µl of radiolabeled in vitro translated product and isolated mitochondria (200 µg of protein). Following the 30-min incubation at 30 °C, the mitochondria were reisolated and washed once as described (33). Proteinase K treatment after the import was performed by adding proteinase K at final concentration of 50 µg/ml to resuspended mitochondria. The proteolytic digest was allowed to proceed at 0 °C for 20 min and was terminated by the addition of phenylmethylsulfonyl fluoride to a final concentration of 1 mM.
Plasmid Construction of HA-tagged COQ6 Two yeast expression plasmids, one single copy and one multicopy, were constructed to express the Coq6 polypeptide containing a carboxyl-terminal peptide (MYPYDVPDYASLDGPMST) corresponding to the carboxyl terminus of the influenza HA viral protein, an epitope for the 12CA5 monoclonal antibody (35). The COQ6 ORF region without the stop codon was PCR-amplified using 5' primer JF3 (5'-ACGCACGCGTCGACATGTTCTTTTCAAAAGTTATGC-3') and 3' primer JF4 (5'-ATAAGAATGCGGCCGCAGTTTCTCATTTCCTCCTAATGTG-3'). The PCR product was directionally cloned into the multicopy pADCL vector (SalI and NotI at 5' and 3', respectively) (36), to generate pHA6. pSHA6, a single copy version of COQ6-HA construct, was generated by removing the 3.6-kb transcriptional cassette from pHA6 by BamHI partial digestion and insertion into BamHI site of the vector pRS316 (23). The yeast cells were transformed with pHA6, pSHA6, or pSR1-1 (25). Transformants were selected for the presence of either the LEU2 (pHA6) or URA3 (pSHA6) gene on SDLeu or SDUra plate media. Colonies obtained on the respective plate medium were subsequently replica-plated to YPG plate medium.
Generation of Antisera against Coq6pThe 1.44-kb
COQ6 ORF was PCR-amplified with forward primer pPG6F
5'-GCGGATCCGATGTTCTTTTCAAAAGTTATGCTT-3' and a reverse
primer pPG6R 5'-GCGGATCCTCATTTCTCATTTCCTCCTAATGTG-3'
and Vent DNA polymerase. The product was then digested with BamHI and
inserted into PET15b (Novagen) at the BamHI site to generate a fusion
protein containing a His6 tag at the amino terminus. The fusion
protein was overexpressed in the E. coli BL21(DE3) under induction by
1 mM isopropyl--D-thiogalactopyranoside and was
purified over His-Bind resin (Novagen) and used to generate antiserum in
rabbits (Cocalico).
Mitochondrial Localization of Coq6pYeast cultures (W303-1A) were grown in YPGal to an A600 nm between 2 and 4, and mitochondria were isolated and purified as described above. Mitoplasts were generated by hypotonic treatment of mitochondria (19). Mitochondria (1 mg of protein) were suspended in five volumes of 20 mM HEPES-KOH, pH 7.4, and incubated on ice for 20 min. The mixture was then sedimented in a microcentrifuge for 10 min at 4 °C to separate the intermembrane space components (supernatant) and the mitoplasts (pellet). The mitoplasts were then sonicated and centrifuged at 150,000 x g for 60 min at 4 °C to generate matrix (supernatant) and membrane (pellet) fractions. Alternatively, the mitoplasts were alkaline-extracted by incubating with 0.1 M Na2CO3, pH 11.5, for 30 min on ice, followed by centrifugation at 150,000 x g for 60 min at 4 °C to separate the integral membrane components (pellet) from the peripheral membrane and matrix components (supernatant) (37). Proteinase K protection experiments were carried out as described (38). The samples were analyzed by immunoblot.
Immunoblot AnalysisThe fractions were assayed for protein
concentration by the bicinchoninic acid assay (Pierce). Equal amounts of
protein from the mitochondrial fractions of cells were analyzed by
electrophoresis on 12% Tris/glycine gels and were subsequently transferred to
Hybond ECL Nitrocellulose (Amersham Biosciences). Immunoblot analysis and
treatment of membranes for reuse with another antisera were performed as
described by Amersham Biosciences. An exception to the stated protocol was the
use of washing buffer: 1x phosphate-buffered saline, 0.1% Tween 20.
Primary antibodies were used at the following concentrations: anti-Coq6p,
1:500; anti-Coq3p, 1:1000; anti-Coq4p, 1:1000; anti-cytochrome
b2, 1:1000; anti-Hsp60p, 1:10,000; anti- subunit of
F1-ATPase, 1:10,000; anti-cytochrome c1,
1:1000; anti-OM45p, 1:1000; and anti-Mas2p, 1:1000. Goat anti-rabbit secondary
antibodies conjugated to horseradish peroxidase (Calbiochem) were used at a
1:10,000 dilution.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The one-step gene replacement procedure
(24) was used to obtain
strains harboring disrupted alleles of the COQ6 gene
(W303COQ6-1,
W303
COQ6-1, and SR
COQ6-1). Analysis
of these strains (see "Experimental Procedures") confirmed the
allelism between the coq6-null mutants and the original
coq6-1 mutant. These data identify the YGR255C ORF as
COQ6.
COQ6 Is Not an Essential GeneIt has been reported that a
complete disruption of the COQ6 ORF results in lethality because
heterozygous knockouts failed to produce viable spores containing a
coq6 disruption (16).
However, all of the coq6 mutant strains used in this study were
viable. A complete ORF disruption was created to address this apparent
discrepancy. Three haploid strains (W303-1A, W3031B, and CEN.PK2-1C) were
transformed with a PCR-generated disruption cassette, and all produced viable
disruptants (W303COQ6-2, W303
COQ6-2, and CEN
COQ6-2) as
confirmed by PCR and restriction digest (data not shown). Similarly, a
W303-1AB diploid was created by mating W303-1A with W303-1B and was
transformed using the same cassette. The heterozygous
COQ6/coq6 diploid strain was subjected to sporulation and
tetrad dissection. Each of the 10 tetrads analyzed produced four viable spores
on YPD plate medium. The spores from each tetrad showed a 2:2 segregation for
respiratory competence and leucine auxotrophy. These results indicate that the
COQ6 gene is not essential for viability but is required for growth
on nonfermentable carbon sources.
Yeast coq6-null Mutants Lack Q6 and
Accumulate HHB Growth of coq6-1 mutants in the presence of
4-[U-14C]hydroxybenzoic acid, the ring precursor in Q biosynthesis,
showed this mutant lacked Q6 and accumulated HHB
(15). HHB is an early
intermediate in the Q biosynthetic pathway and accumulates in mutant yeast
strains harboring deletions or disruptions in any one of the COQ3, COQ4,
COQ5, COQ7,or COQ8/ABC1 genes
(15,
29,
31,
40,
41). To characterize the
defect in Q biosynthesis in a coq6-null mutant, both SR128-3C
(coq6-1) and W303COQ6-1 (coq6
) were grown in
the presence of 4-[U-14C]hydroxybenzoic acid, and lipid extracts
were analyzed by normal phase HPLC as described under "Experimental
Procedures." Both strains lacked Q6 and accumulate a
radioactive intermediate that co-migrated with HHB in fraction 26
(Fig. 3). Neither SR128-3C nor
W303
COQ6-1 was observed to produce Q6 as analyzed by
electrochemical detection, a method that can detect as little as 2 pmol of
Q6/mg of wet weight of yeast. Q6 levels of W303-1A and
W303
COQ6-1:pSR1-1 were 187 and 148 pmol/mg of wet weight of yeast,
respectively, when grown to log phase, and were 189 and 169 pmol/mg of wet
weight of yeast, respectively, when grown to the stationary phase (data not
shown).
|
Coq6p May Act as a Flavin-dependent Monooxygenase to Catalyze Quinone FormationThe predicted amino acid sequence of the COQ6 ORF revealed 21 and 24% sequence identity with the respective E. coli UbiH and UbiF polypeptides (Fig. 4). E. coli ubiH mutants lack Q8 and accumulate compound 6, indicating that UbiH is required for the monooxygenase step that catalyzes quinone formation (Fig. 1 and Ref. 42). The ubiH gene product was identified as a flavin-dependent monooxygenase (43). The E. coli ubiF gene product has also been identified as a flavin-dependent monooxygenase, with 31% amino acid sequence identity to UbiH (44). E. coli ubiF mutants lack Q8, accumulate compound 8, and both ubiH and ubiF mutants fail to grow on media containing succinate (Fig. 1 and Ref. 45). Coq6p, UbiH, UbiF, and other eukaryotic homologs of Coq6 each contain three regions with amino acid sequence identities that are present in a large family of flavin-dependent monooxygenases (Fig. 5 and Ref. 46). Region 1 contains an ADP-binding fingerprint (47), Region 2 is implicated in the recognition of NAD(P)H and may also be involved indirectly in binding the pyrophosphate moiety of FAD (48), whereas Region 3 contains a consensus sequence for binding to the ribityl moiety of FAD (49). Based on the homology with UbiH, and UbiF and the presence of the conserved motifs found in other aromatic flavin-dependent monooxygenases, it seems likely that Coq6p functions in one or more hydroxylation steps in Q biosynthesis.
|
|
Mitochondrial Import of Coq6pThe amino-terminal sequence
predicted for Coq6p showed characteristics of mitochondrial targeting
sequences (14). The first 28
amino acid residues are abundant in positively charged amino acid residues and
devoid of acidic residues. Arrangement of these 28 residues in a helical wheel
shows the positively charged residues are located along one side of the
-helix. The amino-terminal region contains the sequence motif common in
many mitochondrial matrix proteins that are proteolytically cleaved twice once
imported into matrix, as characterized by an arginine at 10, a
hydrophobic residue (phenylalanine, leucine, or isoleucine) at 8, and
serine, threonine, or glycine at 5 relative to the amino-terminal
residue of the proteolytically processed protein. To determine whether Coq6p
is a mitochondrial protein, an in vitro mitochondrial import assay of
the Coq6 polypeptide was performed. Upon incubation with mitochondria prepared
from wild type yeast, the in vitro translated Coq6p was cleaved, and
the resulting mature form of the protein was observed to have a mass of about
51 kDa, consistent with lysine 21 as the putative cleavage site
(Fig. 6). This mature protein
was protected and resistant to exogenous proteinase K treatment
(Fig. 6, lane 3).
Disruption of mitochondrial membrane with detergent exposed the imported and
processed Coq6p, which became accessible to the proteinase K
(Fig. 6, lane 4). The
import of Coq6p also required a mitochondrial membrane potential, because the
addition of valinomycin inhibited import of Coq6p
(Fig. 6, lanes 5 and
6).
|
Mitochondrial Localization of Coq6pOur initial investigation of the subcellular localization of Coq6p made use of a carboxyl-terminal fusion protein between Coq6p and the HA epitope peptide (see "Experimental Procedures"). The Coq6-HA epitope fusion protein retained activity as assayed by the ability of either the single- or multi-copy plasmid construct to rescue coq6-null mutant yeast strains for growth on medium containing a nonfermentable carbon source (YPG plates; data not shown). However, subsequent subcellular and submitochondrial fractionation analysis revealed that the Coq6-HA tagged construct was present in mitochondria as an insoluble aggregate because it remained in the pellet following treatment with 1% Triton X-100 and 1 M NaCl. For this reason, antibodies were generated to the Coq6 polypeptide.
A polyclonal antibody was generated in rabbit against a Coq6-His-tagged
fusion protein. This antibody recognized a polypeptide of 51 kDa in wild type
yeast cell extracts and also recognized the Coq6 HA-tagged polypeptide that
migrates at about 57 kDa (Fig.
7a). No polypeptide at these molecular weights was
detected in cell extracts of the coq6 deletion strain, indicating
that the antibody is specific for Coq6p. Western blot analysis of subcellular
yeast fractions revealed that Coq6p co-fractionated with the mitochondria
along with Coq4p, Coq3p, and cytochrome b2
(Fig. 7b). To
determine whether Coq6p is a membrane-bound or soluble protein, purified
mitochondria were osmotically shocked to disrupt the outer membrane and
release components of the intermembrane space. Mitoplasts were then further
disrupted by sonication to separate the remaining soluble and membrane
components. Fig. 7c
shows that Coq6p localizes to the membrane (pellet) fraction. To determine
whether Coq6p resides in the inner or outer membrane, mitochondria were
treated with combinations of proteinase K, Triton X-100, and hypotonic
swelling. Fig. 7d
shows that Coq6p is degraded only when the detergent is present, as is the
case for two matrix proteins, Hsp60p and Mas2p. Finally, to determine whether
Coq6p is a peripheral or integral protein in the inner mitochondrial membrane,
mitoplasts were treated with 0.1 M sodium carbonate buffer, pH
11.5. Fig. 7e shows
that following this treatment Coq6p is released into the supernatant, as are
the subunit of F1-ATPase and Coq4p (two peripheral membrane
proteins), whereas cytochrome c1 (an integral membrane
protein) is not.
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
S. cerevisiae is a facultative anaerobe capable of fermentation and aerobic respiration, and none of the other COQ genes have been identified as being essential. Complete deletions of the COQ6 gene were introduced into both haploid and diploid strains of W303 and also into CEN.PK2-1C, a haploid strain similar in genetic background to the diploid used by Fiori et al. (16). In contrast to their results, all of the yeast strains were viable when COQ6 was deleted, indicating that none of the eight COQ genes is essential. Q itself is nonessential for growth in this organism.
The function of Coq6p is still unknown, as are the functions of Coq4p and Coq8p. Based on sequence homology to known flavin dependent monooxygenases, it is likely that Coq6p acts similarly. Although Coq6p and UbiF share 24% sequence identity, it seems unlikely that Coq6p functions like UbiF in the hydroxylation of compound 8 in yeast, because previous studies have shown that yeast Coq7p is required for this hydroxylation step (29). The Coq7 polypeptide has been identified as a di-iron carboxylate protein, a member of a monooxygenase family distinct from UbiF (51). Although E. coli lack a homolog of Coq7p, homologs of yeast Coq7p from other prokaryotic species rescue the E. coli ubiF hydroxylase mutants, indicating that these two distinct types of monooxygenases each catalyze the same reaction in Q biosynthesis (51). Currently, two of the uncharacterized steps in Q biosynthesis are hydroxylations, and Coq6p may be responsible for either or both of these steps. Coq6p has 21% identity to the E. coli UbiH, which converts compound 6 to compound 7. Of course other hydroxylation substrates for Coq6p are also possible, including the hydroxylation of HHB to compound 4 (Fig. 1). Indeed, because coq6-1 and coq6-null mutants both accumulate HHB (Fig. 3), it seems attractive to postulate its action at this step. However, the accumulation of HHB is not diagnostic of the blocked step, because so many other coq mutants also accumulate HHB (15). Another possibility is that Coq6p catalyzes the oxidative decarboxylation of compound 5 to compound 7. It has been demonstrated that 4-hydroxybenzoate 1-hydroxylase oxidatively decarboxylates 4-hydroxybenzoic acid with the formation of hydroquinone (52). Salicylate hydroxylase similarly oxidatively decarboxylates salicylate to catechol (53). However, in yeast this is less likely given that previous work showed a Q-deficient yeast mutant accumulated compound 6 (54). That mutant was never sequenced, nor is it available. Identification of the role of Coq6p in the hydroxylation step(s) of Q biosynthesis will require development of in vitro assays for these hydroxylation steps.
Blast analysis of Coq6p against other higher eukaryotic genomes revealed that only one homolog existed for Homo sapiens, Mus musculus, and C. elegans, indicating a conserved evolution for this protein (Fig. 4). For Drosophila melanogaster, two matches were found, but only one had a high score and spanned the entire sequence. The homologs in each case retained the three conserved motifs depicted in Fig. 5.
Genetic data have suggested that a putative complex of these Coq polypeptides is responsible for Q biosynthesis because a deletion in any one of the eight COQ genes results in a profound decrease in steady state protein levels for Coq3p, Coq4p, and Coq7p (34).2 Furthermore, null mutations in coq3, coq4, coq5, coq7,or coq8/abc1 result in the accumulation of HHB (15). Similarly, analyses of lipid extracts of coq6 mutants in the studies presented here show that these mutants also accumulate HHB. It has been observed that an E226K coq4 point mutant did allow for the steady state expression of Coq3p and Coq7p (40). In addition, a G104D coq7 point mutant allowed for the accumulation of 2-hexaprenyl-3-methyl-6-methoxy-1,4-benzoquinone (Fig. 1, demethoxy-Q or compound 8) (29). It would appear that both the coq4 and coq7 amino acid substitution mutants allow for the expression of correctly folded but inactive Coq4p and Coq7p, respectively, and each may be interacting and stabilizing the steady state expression of the other Coq polypeptides in a complex. The accumulation of HHB in both the coq6 mutants further suggests that Coq6p similarly is required for stabilization of a complex. Additionally, the coq6-1 mutant has been found to be a nonsense mutation of the tyrosine at position 218.3 This mutant would be unable to produce a stable polypeptide at full length and would explain why we see an accumulation of HHB.
![]() |
FOOTNOTES |
---|
Present address: Dept. of Chemistry, University of Utah, 315 South 1400 E,
Salt Lake City, UT 84112-0850.
|| To whom correspondence should be addressed: Dept. of Chemistry and Biochemistry, University of California, Los Angeles, 607 Charles E. Young Dr. East, Los Angeles, CA 90095-1569. Tel.: 310-825-0771; Fax: 310-206-5213; E-mail: cathy{at}mbi.ucla.edu.
1 The abbreviations used are: Q, ubiquinone or coenzyme Q; HHB,
3-hexaprenyl-4-hydroxybenzoic acid; ORF, open reading frame; HPLC, high
performance liquid chromatography; HA, hemagglutinin.
2 P. Gin and C. F. Clarke, unpublished data.
3 E. Hsieh and C. F. Clarke, unpublished data.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|